EOLS Q1 2020 Earnings — Evolus, Inc. Revenue & Financial Results | Market Cap Arena

EOLSEvolus, Inc.

$338M

Q1 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$10M

Gross Profit

$5M43.1% margin

Operating Income

-$27M-259.9% margin

Net Income

-$20M-188.0% margin

EPS (Diluted)

$-0.59

QoQ Revenue Growth

-46.0%

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$29M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$214M

Total Liabilities

$152M

Stockholders' Equity

$63M

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$0	—
Gross Profit	$5M	$0	—
Operating Income	-$27M	-$25M	-8.0%
Net Income	-$20M	-$11M	-79.8%